menu search

SRRK / Down 43.1% in 4 Weeks, Here's Why You Should You Buy the Dip in Scholar Rock Holding Corporation (SRRK)

Down 43.1% in 4 Weeks, Here's Why You Should You Buy the Dip in Scholar Rock Holding Corporation (SRRK)
Scholar Rock Holding Corporation (SRRK) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock. Read More
Posted: May 20 2022, 11:17
Author Name: Zacks Investment Research
Views: 111622

SRRK News  

Here's Why 'Trend' Investors Would Love Betting on Scholar Rock Holding Corporation (SRRK)

By Zacks Investment Research
October 31, 2023

Here's Why 'Trend' Investors Would Love Betting on Scholar Rock Holding Corporation (SRRK)

If you are looking for stocks that are well positioned to maintain their recent uptrend, Scholar Rock Holding Corporation (SRRK) could be a great choi more_horizontal

Scholar Rock: SMA Data Readout In 2024 Makes This Worth A Look

By Seeking Alpha
October 25, 2023

Scholar Rock: SMA Data Readout In 2024 Makes This Worth A Look

The Scholar Rock Holding Corporation phase 3 SAPPHIRE study for apitegromab for the treatment of type 2 and type 2 SMA patients has completed enrollme more_horizontal

All You Need to Know About Scholar Rock Holding Corporation (SRRK) Rating Upgrade to Strong Buy

By Zacks Investment Research
October 24, 2023

All You Need to Know About Scholar Rock Holding Corporation (SRRK) Rating Upgrade to Strong Buy

Scholar Rock Holding Corporation (SRRK) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings pr more_horizontal

Scholar Rock (SRRK) Up on Pipeline Advancement, Stock Offering

By Zacks Investment Research
October 13, 2023

Scholar Rock (SRRK) Up on Pipeline Advancement, Stock Offering

Scholar Rock (SRRK) rises on plans to advance SRK-439 for treating obesity and offering common stock. more_horizontal

Why Scholar Rock Holding Stock Soared Today

By The Motley Fool
October 12, 2023

Why Scholar Rock Holding Stock Soared Today

Scholar Rock announced it will advance the development of its obesity treatment, SRK-439, starting with a phase 2 proof-of concept trial in 2024. The more_horizontal

Scholar Rock: The Market Isn't Enthusiastic Despite Decent Clinical Data

By Seeking Alpha
August 27, 2023

Scholar Rock: The Market Isn't Enthusiastic Despite Decent Clinical Data

Scholar Rock Holding Corp. is developing a growth factor targeted therapy called apitegromab for Spinal Muscular Atrophy. Positive interim data from a more_horizontal

Scholar Rock to Present at the Cowen 43rd Annual Health Care Conference

By Business Wire
February 27, 2023

Scholar Rock to Present at the Cowen 43rd Annual Health Care Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious more_horizontal

Why Scholar Rock Stock Flew High Today

By The Motley Fool
June 27, 2022

Why Scholar Rock Stock Flew High Today

A venture capital group significantly increased its stake in the company. more_horizontal


Search within

Pages Search Results: